Invention Grant
- Patent Title: Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
-
Application No.: US16211159Application Date: 2018-12-05
-
Publication No.: US11433097B2Publication Date: 2022-09-06
- Inventor: Maria Fardis
- Applicant: Iovance Biotherapeutics, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Iovance Biotherapeutics, Inc.
- Current Assignee: Iovance Biotherapeutics, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K35/17
- IPC: A61K35/17 ; G01N33/574 ; C12N5/0783 ; A61P35/04 ; C12N5/078 ; A61K35/00
Abstract:
Methods of treating melanomas refractory to other therapies using tumor infiltrating lymphocytes are disclosed. Also disclosed is the use of IP-10 as a biomarker for predicting treatment efficacy.
Public/Granted literature
- US20190231820A1 METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA Public/Granted day:2019-08-01
Information query
IPC分类:
